Dexmedetomidine as Adjuvant for FNB in TKA

• Status: Completed
• Trial end date: 2018-11-10
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study was to find out whether addition of dexmedetomidine to lower concentration of ropivacaine preoperatively in femoral nerve block (FNB) would intensify analgesia and preserve quadriceps muscle strength after TKA.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Dexmedetomidine; Morphine; Ropivacaine

Criteria

Inclusion Criteria:

• ASA I-II

• scheduled for total knee arthroplasty

Exclusion Criteria:

• refusal to participate in this study

• unicompartmental knee arthroplasty

• BMI > 35 kg/m2

• congnitive or phychiatric history

• refusal of general anesthesia

• contraindication to laryngeal mask airway insertion

• contraindication to peripheral nerve block (localized infections, sepsis, coagulopathy, bleeding diathesis or preexisting lower extremity neurological abnormality)

• allergy to the drugs used